Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States
Author:
Funder
Office of the Director
Tohoku University
National Institutes of Health
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference46 articles.
1. Olaparib for metastatic castration-resistant prostate cancer;de Bono;N. Engl. J. Med.,2020
2. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer;Golan;N. Engl. J. Med.,2019
3. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation;Litton;N. Engl. J. Med.,2018
4. Poly(ADP-ribose) polymerase inhibitors in the management of ovarian cancer: ASCO guideline rapid recommendation update;Tew;J. Clin. Oncol.,2022
5. U.S. food and drug administration-approved poly (ADP-ribose) polymerase inhibitor maintenance therapy for recurrent ovarian cancer: a cost-effectiveness analysis;Dottino;Obstet. Gynecol.,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cross‐sectional analysis of pharmaceutical industry payments to board‐certified breast cancer specialists in Japan;Clinical and Translational Discovery;2024-08
2. Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis;BMJ Open;2024-07
3. Pharmaceutical company payments to Japanese breast cancer practice guideline authors;Clinical and Translational Discovery;2024-06
4. Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan;BMC Medical Ethics;2024-02-20
5. Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021;Leukemia & Lymphoma;2024-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3